New Blood for Soviet Academy

LONDON—Younger directors will soon be appointed to about one-half of the 260 institutions directed by the Academy of Sciences of the U.S.S.R. This follows the recent announcement by the new president of the academy, Guri Marchuk, that directors must retire at age 70 rather than holding their appointments for life, as is now the case. In addition to directors now being "prematurely" retired, many other senior scientists who enjoyed lifelong tenure will have to leave their posts when they re

Written byBernard Dixon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The rejuvenation of Soviet science is being hastened by theintroduction of "recertification" for researchers. According to Izvestia, more than 2 percent of the scientists have failed these tests and been dismissed, while an additional 5 percent have been demoted. The future of scientists who fail recertification is uncertain, but the septuagenarian directors now leaving their posts will continue to draw their present salaries after being given such titles as "counselor to the Presidium of the U.S.S.R. Academy of Sciences."

"Everything gets fatigued—even metal," writes Yevgeniya Albats in Moscow News in explaining Marchuk's "reconstruction" of the Academy. "The same is true of people, even those with outstanding potential.

"Science calls for a versatile mind and new ideas," Albats continued. "It doesn't tolerate stagnation. Authoritarianism in science is equal to death. The essence of this innovation by the Academy consists precisely in that it recognizes that one must not hold a position ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies